Covered recipient · General Payments record
TEMPLE W SIMPSON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$10,462.33
- Reported across 544 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,357.73 | 115 |
| Education | $22.80 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $262.03 | 14 |
| Lilly USA, LLC | $256.33 | 12 |
| SANOFI-AVENTIS U.S. LLC | $236.14 | 7 |
| Abbott Laboratories | $211.26 | 10 |
| Medtronic, Inc. | $193.22 | 17 |
| Insulet Corporation | $151.35 | 7 |
| ABBVIE INC. | $125.78 | 6 |
| Bayer HealthCare Pharmaceuticals Inc. | $107.65 | 5 |
| Xeris Pharmaceuticals, Inc. | $98.00 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.61 | 4 |
| Averitas Pharma Inc. | $61.88 | 2 |
| BETA BIONICS, INC. | $56.56 | 2 |
| Amgen Inc. | $55.22 | 3 |
| Corcept Therapeutics | $45.95 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $44.25 | 2 |
| Antares Pharma, Inc. | $44.11 | 2 |
| Ascensia Diabetes Care US Inc. | $43.52 | 2 |
| CeQur Corporation | $34.89 | 1 |
| Nevro Corp. | $34.56 | 1 |
| TOLMAR, INC. | $32.71 | 2 |
| Kyowa Kirin, Inc. | $28.90 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.38 | 1 |
| IBSA Pharma Inc. | $23.87 | 1 |
| OPKO Pharmaceuticals, LLC | $22.80 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.46 | 1 |
| Ascendis Pharma Inc | $22.29 | 1 |
| SHIELD THERAPEUTICS INC | $20.11 | 1 |
| Amneal Pharmaceuticals LLC | $19.76 | 1 |
| Astellas Pharma US Inc | $16.14 | 1 |
| DEXCOM, INC. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (116)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.